GlassScriptPhysician profile
Mina A Ibrahim
NPI 1497289342
$4,371.56
in general payments reported to CMS, 2019-2025
9 companies · $3,585 in 2025
The $3,585 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $26.16 · 2023: $124 · 2024: $444 · 2025: $3,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,477 · Food and Beverage: $1,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,476.62 |
| Food and Beverage | $1,676.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,646.43 | 2024-2025 | Gore Synecor Biomaterial, Gore Bio-A Tissue Reinforcement, Seamguard Staple Line Reinforcement |
| Intuitive Surgical, INC. | $1,160.78 | 2023-2025 | |
| Medical Device Business Services, INC. | $1,039.63 | 2025 | Linx Reflux Management System |
| Davol INC. | $156.06 | 2021 | |
| Novo Nordisk INC | $119.27 | 2021-2023 | Wegovy |
| Ethicon US, LLC | $105.27 | 2024 | Echelon; Endopath, Echelon Flex |
| Teleflex LLC | $88.33 | 2025 | Titan Sgs Bailout Chuck |
| Intra-Sana Laboratories | $29.63 | 2024-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Convatec INC. | $26.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.